Impact Clinical Trials

Las Vegas, Nevada 89206

0 studies enrolling now · 21 studies all time

What they study most

Androgenetic Alopecia, Asthma, Chlamydial Infection, Chronic Anal Fissures, Chronic Hepatitis C, Chronic Pain, Contraception, Diabetes Mellitus, Diabetes Mellitus Complications, Diabetes Type 2, Diabetic Foot Ulcer, Female Pattern Baldness

Studies at this site

• A Prospective, Randomized, Double-Blind Multicenter Study Comparing CDO Therapy to Standard MWT in the Treatment of DFUs — Completed
• Setmelanotide Phase 2 Treatment Trial in Participants With Rare Genetic Disorders of Obesity — Completed
• Study of Contraceptive Efficacy & Safety of Phexxi™ (Previously Known as Amphora) Gel Compared to Conceptrol Vaginal Gel — Completed
• Clinical Study of a Diagnostic Device for NG, TV and CT in Women — Completed
• A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation — Completed
• A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis — Completed
• Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone — Completed
• Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee — Completed
• Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus — Completed
• Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis — Completed
• A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine. — Completed
• A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response — Completed
• A Study in Participants With Asthma Initiating Treatment With Omalizumab (Xolair) — Completed
• DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension — Completed
• GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype — Stopped early
• Efficacy and Safety Study With Diltiazem Hydrochloride Cream to Treat Anal Fissures — Completed
• DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension — Stopped early
• A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004669) — Completed
• Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-9669 in Subjects With Chronic Hepatitis C Virus Infection — Completed
• A Study of the Effectiveness and Safety of Ramipril in the Treatment of Hypertension in Children and Adolescents — Stopped early
• A Study of Topical Danazol for the Treatment of Pain Associated With Fibrocystic Breast Disease — Completed